5.  Outpatient COVID-19 Therapeutics

5. Outpatient COVID-19 Therapeutics

Update: 2022-07-29
Share

Description

There were not many COVID-19 treatment options available in 2020 & 2021.  Now there are at least four that can be used for non-hospitalized patients.  The frequent changes may have been difficult to keep up with. difficult to keep up with all the changes. Timothy Ott, DO, FAAFP, IAFP President, and Mustafa Alavi, MD, breakdown the options and share resources to help physicians feel more comfortable in selecting and prescribing the correct medication for each of their patients.

Discussions will cover:
-          Indication & Dosing
-          Efficacy
-          Contraindications and Side Effects
-          Availability & Cost
-          Tips with prescribing/obtaining medication

Treatments will include:

-          Paxlovid – oral
-          Remdesivir – IV
-          Bebtelovimab – IV
-          Molnupiravir – oral

Physician experts will also cover misinformation about treatments that may have been considered or discussed in the media.  Finally, an option to help PREVENT COVID-19 in some of the most high-risk patients who are already fully vaccinated will be discussed.

Objectives:

-          Understand the evolution of outpatient therapeutics used to treat COVID-19

-          Determine which of the treatment options are best for your patients

-          Identify treatments that the FDA warns against using

-          Discuss an option to help PREVENT COVID-19 

Visit us at illinoisvaccinates.com/podcasts.

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

5.  Outpatient COVID-19 Therapeutics

5. Outpatient COVID-19 Therapeutics

I-VAC & IAFP